Home
>
National Drug Code (NDC)
>
Aztreonam
Aztreonam - 63323-397-20 - (AZTREONAM)
Drug Information of Aztreonam
| Product NDC: | 63323-397 |
| Proprietary Name: | Aztreonam |
| Non Proprietary Name: | AZTREONAM |
| Active Ingredient(s): | 500 mg/1 & nbsp; AZTREONAM |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Aztreonam
| Product NDC: | 63323-397 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065439 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091105 |
Package Information of Aztreonam
| Package NDC: | 63323-397-20 |
| Package Description: | 10 VIAL in 1 TRAY (63323-397-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of Aztreonam
| NDC Code | 63323-397-20 |
| Proprietary Name | Aztreonam |
| Package Description | 10 VIAL in 1 TRAY (63323-397-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 63323-397 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | AZTREONAM |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20091105 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | AZTREONAM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient] |
